BackActuate Therapeutics Overview
Actuate Therapeutics Inc.

Actuate Therapeutics Target Price

Analysts' 12-month price predictions for ACTU.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.02

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-04-22Craig-Hallum$21939.6% upsideOpen